<DOC>
	<DOCNO>NCT01920321</DOCNO>
	<brief_summary>Aim : To evaluate feasibility , safety efficacy relatively simple approach bronchoscopic lung volume reduction ( LVR ) technology , independent collateral ventilation . Description : Patients severe upper lobe heterogeneous emphysema , undergo unilateral bronchoscopic installation saline thermal energy 50-55 ºC intending induce inflammatory airway parenchymal injury consequently fibrotic response result LVR ;</brief_summary>
	<brief_title>Bronchoscopic Thermal Saline Ablation ( BTSA ) Emphysematous Lung . A New Emphysema Therapy</brief_title>
	<detailed_description>Inclusion criterion : 1 . Age 40-75 unlimited sex . 20 subject 2. chronic obstructive pulmonary disease ( COPD ) , GOLD 3-4 ( global obstructive lung disease ) . 3 . CT scan lung include high resolution slice . Demonstrating emphysematous , bullotic change upper lobe . 4 . Pulmonary function test results- total lung capacity ( TLC ) &gt; 110 % , residual volume ( RV ) &gt; 150 % , diffusion lung CO ( DLCO ) &lt; 80 % , forced expiratory volume 1 second ( FEV1 ) :15-45 % . 5 . 6 minute walk distance ( 6MWD ) &gt; 140 meter . Exclusion criterion : 1 . Active ischemic heart disease , significant arrhythmia . ejection fraction ( EF ) &lt; 40 % . 2 . COPD cause carbon bioxide ( CO2 ) retention 50 mm Hg / oxygen saturation rest 88 % . 3 . Pulmonary hypertension &gt; 45 mmHg , accord Echo Test . 4. . Cancer treatment chemotherapy / radiation expect life expectancy less two years.5 . Pregnancy . Methods : . A . Patient preparation sedation diagnostic bronchoscopy . Sedation base midzoln + demerol . The patient treat prior treatment Inhalation salbutamol an ipratropium bromide . Flexible bronchoscope outer diameter 5 mm introduce targated upper lobe , place wedge position . This follow installion 0.9 % natriu , chloride ( NaCl ) temperature 55ºC exit temperature 50ºC ) portion 40 ml 200 ml ( bronchoalveolar lavage 300 ml acceptable . The patient place horizontal position , continuous ECG blood pressure . Oxygen saturation monitor . This monitoring continue least 2 hour treatment . A chest x-ray follow patient remain department overnight . Tracking : Minimum 6 month - Outpatient follow include addition physical examination extend pulmonary function test 3-6 month . low radiation chest CT .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>1 . Age 4075 unlimited sex . 20 subject 2 . COPD , GOLD 34 ( global obstructive lung disease ) . 3 . CT scan lung include high resolution slice . Demonstrating emphysematous , bullotic change upper lobe . 4 . Pulmonary function test result TLC &gt; 110 % , RV &gt; 150 % , DLCO &lt; 80 % , FEV1 : 1545 % . 5 . 6 minute walk distance &gt; 140 meter . 1 . Active ischemic heart disease , significant arrhythmia . Ejection fraction ( EF ) &lt; 40 % . 2 . Chronic lung disease cause CO2 retention 50 mm Hg / oxygen saturation rest 88 % . 3 . Pulmonary hypertension &gt; 45 mmHg , accord Echo Test . 4. . Cancer treatment chemotherapy / radiation expect life expectancy less two year . 5 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>Bronchoscopic LVR</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Hot injury</keyword>
</DOC>